vimarsana.com

துறை ஆஃப் நோயெதிர்ப்பு நுண்ணுயிரியல் இல் ஸ்கிரிப்ட்கள் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers discover cross-reactive coronavirus antibody triggered during COVID-19 infection

Versatile coronavirus antibody may be starting point for broader-acting vaccines

 E-Mail LA JOLLA, CA Even before the COVID-19 pandemic, most people in the United States already had been sick with a coronavirus, albeit a far less dangerous one. That s because at least four coronaviruses in the same general family as SARS-CoV-2 cause the benign yet annoying illness known as the common cold. In a new study that appears in Nature Communications, scientists from Scripps Research investigated how the immune system s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. In doing so, they discovered one cross-reactive coronavirus antibody that s triggered during a COVID-19 infection. The findings will help in the pursuit of a vaccine or antibody treatment that works against most or all coronaviruses, says senior author Raiees Andrabi, PhD, an investigator in the Department of Immunology and Microbiology.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.